Status:
COMPLETED
Risk Factors for Portosinusoidal Vascular Disease in Kidney Transplant Recipients:
Lead Sponsor:
University Hospital, Caen
Conditions:
Porto-Sinusoidal Vascular Disease
Eligibility:
All Genders
18+ years
Brief Summary
To look for the factors of exposure present prior to the onset of Porto-Sinusoidal Vascular Disease (PSVD) and which can lead to the occurrence of PSVD after renal transplantation, and therefore to co...
Detailed Description
Porto-Sinusoidal Vascular Disease (PSVD) is a heterogeneous clinico-pathological entity characterized by alterations in small liver vessels. The most common is known as "nodular regenerative hyperplas...
Eligibility Criteria
Inclusion
- PSVD (between january 2000 and december 2021) after kidney transplantation or
- Kidney transplantation without PSVD or
- PSVD without kidney transplantation
Exclusion
- liver cirrhosis
- transplanted from an other organ
- thrombocytopenia and/or abnormal liver tests and/or hepatic dysmorphism and/or portal hypertension signs
Key Trial Info
Start Date :
October 25 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2023
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT05388409
Start Date
October 25 2021
End Date
December 30 2023
Last Update
March 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu de Caen
Caen, Calvados, France, 14033